📰 Breaking News: Lessons Learnt & Insights from UK’s first and to date only SME Restructuring Plan

Apex Biologics Consulting LTD enters members' voluntary liquidation

Active Company no. 11951841 Incorporated Apr 2019 Professional Services CB postcode area

Companies House record →

Wiggons Farm Wiggens Green, Helions Bumpstead, Haverhill, CB9 7AD

The most recent insolvency notice for Apex Biologics Consulting LTD is a Resolution for winding up (MVL), published 03 November 2026 in The London Gazette. The office holder is Situl Devji Raithatha (IP No. 8927) of Springfields Advisory LLP, 38 De Montfort Street, Leicester, LE1 7GS, appointed 26 October 2026. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.

Last filed balance sheet

Not yet retrieved.

Insolvency notices (2)

  1. APEX BIOLOGICS CONSULTING LTD resolved to voluntarily wind up the company and appointed Situl Devji Raithatha of Springfields Advisory LLP as liquidator on 26 October 2026.

  2. The liquidator of APEX BIOLOGICS CONSULTING LTD announces final creditor claims and the intended final distribution of assets in a members’ voluntary liquidation.

What happens next

Because this is a solvent liquidation, creditors are paid in full. The liquidator advertises for claims, settles them, distributes the surplus to the shareholders and the company is then dissolved. Anyone owed money should still submit their claim to the liquidator named in the notice, and within the period the notice states.

Owed money by Apex Biologics Consulting LTD?

A bad debt this size rarely stops with the company that failed. If you're a supplier or creditor left short, it's worth knowing where you rank — and checking what the shortfall does to your own cashflow.

What to do when a customer fails

Related guidance

Frequently asked questions

Is Apex Biologics Consulting LTD in financial difficulty?

No — the most recent process is a solvent one. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress. The most recent insolvency notice for Apex Biologics Consulting LTD (company no. 11951841) is a Resolution for winding up (MVL), published 03 November 2026 in The London Gazette.

What were Apex Biologics Consulting LTD's last filed accounts?

Not yet retrieved for Apex Biologics Consulting LTD at Companies House.

How many insolvency notices does Apex Biologics Consulting LTD have?

Apex Biologics Consulting LTD has 2 insolvency notices recorded in The London Gazette, the most recent being a Resolution for winding up (MVL) on 03 November 2026.

What happens next?

Because this is a solvent liquidation, creditors are paid in full. The liquidator advertises for claims, settles them, distributes the surplus to the shareholders and the company is then dissolved. Anyone owed money should still submit their claim to the liquidator named in the notice, and within the period the notice states.

Financial figures are taken from the company's own last accounts filed at Companies House. Small and micro-entity accounts are unaudited, and for a company entering an insolvency process the most recent filing frequently predates that process by a year or more. Figures are indicative and are not a valuation. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright.